<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Altered glycosylation in epithelial <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> may play an important role in <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumour progression</z:e>, as it may affect <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">tumour cell migration</z:e> and antigen presentation by antigen presenting cells </plain></SENT>
<SENT sid="1" pm="."><plain>We specifically characterise the glycosylation patterns of two <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> antigens that are highly expressed in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissue and often detected in their secreted form in serum: the epithelial mucin MUC1 and carcinoembryonic antigen (CEA, also called CEACAM5) </plain></SENT>
<SENT sid="2" pm="."><plain>We analysed 48 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients, comparing <z:mpath ids='MPATH_458'>normal</z:mpath> colon and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> epithelium within each patient </plain></SENT>
<SENT sid="3" pm="."><plain>Lectin binding was studied by a standardised CEA/MUC1 capture ELISA, using several plant lectins, and the human C-type lectins MGL and DC-SIGN, and Galectin-3 </plain></SENT>
<SENT sid="4" pm="."><plain>Peanut agglutinin (<z:chebi fb="3" ids="48021">PNA</z:chebi>) bound to MUC1 from <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> tissue in particular, suggests increased expression of the <z:e sem="disease" ids="C1406916" disease_type="Disease or Syndrome" abbrv="">Thomsen</z:e>-Friedenreich antigen (TF-antigen) (Core 1, <z:chebi fb="125" ids="28260">Gal</z:chebi>β1-3GalNAc-Ser/Thr) </plain></SENT>
<SENT sid="5" pm="."><plain>Only small amounts of Tn-antigen (GalNAcα-Ser/Thr) expression was observed, but the human C-type lectin MGL showed increased binding to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-associated MUC1 </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, sialylation was greatly enhanced </plain></SENT>
<SENT sid="7" pm="."><plain>In sharp contrast, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-associated CEA (CEACAM5) contained high levels of the blood-group related carbohydrates, Lewis X and Lewis Y </plain></SENT>
<SENT sid="8" pm="."><plain>This correlated strongly with the interaction of the human C-type lectin DC-SIGN to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-associated CEA, suggesting that CEA can be recognized and taken up by antigen presenting cells </plain></SENT>
<SENT sid="9" pm="."><plain>In addition, increased <z:chebi fb="0" ids="37684">mannose</z:chebi> expression was observed and branched N-<z:chebi fb="0" ids="18154">glycans</z:chebi> were prominent, and this correlated well with human Galectin-3 binding </plain></SENT>
<SENT sid="10" pm="."><plain>These data demonstrate that individual <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> antigens contain distinct glycan structures associated with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and, since <z:chebi fb="0" ids="18154">glycans</z:chebi> affect cellular interactions with its microenvironment, this may have consequences for progression of the disease </plain></SENT>
</text></document>